Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2013

View Archived Issues

Development of a targeted immunotoxin for the destruction of brain cancer cells in glioblastomas

First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis

PTC Therapeutics identifies novel fused 2-pyridones active against resistant bacteria

Discovery of novel cathepsin K inhibitors for bone resorption

Viriom reports data from international trial of HIV drug candidate

Continued clinical benefit of tildrakizumab for 1 year in chronic psoriasis

2B3-201 as a strategy for sustained and nontoxic release of methylprednisolone

Bharat Biotech launches inactivated Japanese encephalitis vaccine

Boost to MAX BioPharma's oxysterol program through licensing and SBIR grant

Almac Discovery patent describes novel protein kinase Akt inhibitors

Bristol-Myers Squibb prepares and tests HIV attachment inhibitors

Liver X receptor-beta agonists reported in Vitae Pharmaceuticals patent

Minerva Patents presents compound for ischemic reperfusion injury

Bayer selects drug candidates for accelerated development and expands indications for approved drugs

FDA accepts filing of Zerenex NDA

Janssen acquires NS5A inhibitor from GlaxoSmithKline for hepatitis C

University of Queensland and Leo Pharma form strategic skin cancer collaboration

Edimer begins phase II trial in XLHED-affected male newborns

Pfizer in-licenses preclinical program on early-onset morbid obesity

GSK reports results from large-scale phase III trial of malaria vaccine RTS,S

Active Biotech receives milestone payment for tasquinimod trial

FDA approves Adempas for CTEPH and PAH

Hutchison MediPharma and Eli Lilly sign agreement for fruquintinib

Forma Therapeutics meets first objective in collaboration with Celgene

ILC receives orphan drug designation in Europe for osteosarcoma

VAC-3S vaccine: first-in-human safety, dose and immunization results

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...